Enfermedad de Parkinson y depresión Lieberman

Acta Neurológica Scandinavica 2006 (enero); 113 (1)

Eficacia y seguridad de dosis altas de cabergolina en la Enfermedad de Parkinson

Odin, et al.
Acta Neurológica Scandinavica 2006 (enero); 113 (1): 18-24

Enfermedad de Parkinson y Quinasas Tau

Dickson
Annals of Neurology 2005 (diciembre); 58 (6): 819-820

Implante intraestriatal de células epiteliales pigmentadas de retina humana ligadas a microportadores en Enfermedad de Parkinson avanzada

Stover, et al.
Archives of Neurology

Trastornos genéticos en la Enfermedad de Parkinson en especial, sobre la mutación LRRK2

Brice
Brain 2005; 128 (12): 2760-2762

Flujo cerebral regional en Enfermedad de Parkinson con alucinaciones visuales no psicóticas

Oishi, et al.
Neurology 2005; 65 (11): 1708-1715

Olfaction testing in patients with tremor-dominant Parkinson’s disease: Is this a distinct condition?

Ondo, W.G.; Lai, D.J.
Movement Disorders, abril 2005; 20 (4): 471-475.

Tratamiento con Rivastigmina de la Demencia asociada a la Enfermedad de Parkinson

Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G et al. Rivastigmine for Dementia Associated with Parkinson’s Disease.
NEJM 2004; 351: 2509-2518

Dardarin Mutation is a Common Cause of Familial PD

The role of radiotracer imaging in Parkinson disease

B Ravina, D Eidelberg, JE Ahlskog, RL Albin, DJ Brooks, M Carbon, V Dhawan, A Feigin, S Fahn, M Guttman, K Gwinn-Hardy, H McFarland, R Innis, RG Katz, K Kieburtz, SJ Kish, N Lange, JW Langston, K Marek, L Morin, C Moy, D Murphy, WH Oertel, G Oliver, Y Palesch, W Powers, J Seibyl, KD Sethi, CW Shults, P Sheehy, AJ Stoessl, R Holloway
Neurology 2005; 64 :208-215

Long-term follow-up of cervical dystonia patients treated with botulinum toxin type A

P Haussermann, S Marczoch, C Klinger, M Landgrebe, B Conrad, A Ceballos-Baumann
Movement Disorders 2004; 19: 303-308

Improvement of sleep quality in patients with advanced Parkinson’s disease treated with deep brain stimulation of the subthalamic nucleus

N Hjort, K Ostergard, E Dupont
Movement Disorders 2004; 2: 195-199

Effects of bilateral subthalamic stimulation on sleep in Parkinson’s disease

C Monaca, C Ozsancak, JM Jaquesson, I Poirot, S Blond, A Destee, JD Guieu, P Derambure
J Neurol 2004; 251: 214-218

The effects of pramipexole in REM sleep behavior disorder

ML Fantini, JF Gagnon, D Filipini, J Montplaisir
Neurology 2003; 61:1418-1420

Parkinsonism in Ontario: Comorbidity associated
with hospitalization in a large cohort

M Guttman, PM Slaughter, ME Theriault, DP DeBoer, M Math, CD Naylor
Movement Disorders 2004; 19:49-53

Duration of amantadine benefit on dyskinesia of severe Parkinson’s disease

A Thomas, D Iacono, AL Luciano, K Armellino, A Di Iorio, M Onofrj
J Neurol Neurosurg Psychiatry 2004;75:141-143

Spasticity after stroke: Its occurrence and association with motor impairments and activity limitations

DK Sommerfeld, Elsy UB Eek, AK Svensson, LW Holmqvist, MH von Arbin
Stroke 2004;35:134-140

Update sobre tratamiento de las complicaciones motoras en la enfermedad de Parkinson